20-HETE-producing enzymes are up-regulated in human cancers

Cancer Genomics and Proteomics

Volumn 9, Issue 4, 2012, Pages 163-169

  Alexanian, Anna ^a   Miller, Bradley ^a   Roman, Richard J ^b   Sorokin, Andrey ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

20 HETE; 20 Hydroxyeicosatetraenoic acid; CYP4A F; Eicosanoids; HRPTEC cells; Ovarian cancer; Ras

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; CYTOCHROME; CYTOCHROME P450 4A; CYTOCHROME P450 4F; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; COLON CANCER; CONTROLLED STUDY; CYP4F GENE; EPITHELIUM CELL; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY PROXIMAL TUBULE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETER; OVARY CANCER; REAL TIME POLYMERASE CHAIN REACTION; THYROID CANCER; UPREGULATION; WESTERN BLOTTING;

EID: 84864656181     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Wang D and Dubois RN: Prostaglandins and cancer. Gut 55: 115-122, 2006. (Pubitemid 41820645)
2. Wang D and Dubois RN: Eicosanoids and cancer. Nat Rev Cancer 10: 181-193, 2010.
3. Lin F, Rios A, Falck JR, Belosludtsev Y and Schwartzman ML: 20-Hydroxyeicosatetraenoic acid is formed in response to EGF and is a mitogen in rat proximal tubule. Am J Physiol 269: F806-F816, 1995.
4. Chen P, Guo M, Wygle D, Edwards PA, Falck JR, Roman RJ and Scicli AG: Inhibitors of cytochrome P450 4A suppress angiogenic responses. Am J Pathol 166: 615-624, 2005. (Pubitemid 40189056)
5. Guo AM, Arbab AS, Falck JR, Chen P, Edwards PA, Roman RJ and Scicli AG: Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation. J Pharmacol Exp Ther 321: 18-27, 2007. (Pubitemid 46456964)
6. Guo M, Roman RJ, Fenstermacher JD, Brown SL, Falck JR, Arbab AS, Edwards PA and Scicli AG: 9L gliosarcoma cell proliferation and tumor growth in rats are suppressed by N-hydroxy-N′-(4-butyl-2-methylphenol) formamidine (HET0016), a selective inhibitor of CYP4A. J Pharmacol Exp Ther 317: 97-108, 2006.
7. Alexanian A, Rufanova VA, Miller B, Flasch A, Roman RJ, and Sorokin A: Down-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell proliferation and tumor growth. Anticancer Res 29: 3819-3824, 2009.
8. Miyata N and Roman RJ: Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system. J Smooth Muscle Res 41: 175-193, 2005. (Pubitemid 41596358)
9. Miyata N, Taniguchi K, Seki T, Ishimoto T, Sato-Watanabe M, Yasuda Y, Doi M, Kametani S, Tomishima Y, Ueki T, Sato M and Kameo K: HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme. Br J Pharmacol 133: 325-329, 2001. (Pubitemid 33027767)
10. Seki T, Wang MH, Miyata N and Laniado-Schwartzman M: Cytochrome P450 4A isoform inhibitory profile of N-hydroxy-N′-(4-butyl-2-methylphenyl)- formamidine (HET0016), a selective inhibitor of 20-HETE synthesis. Biol Pharm Bull 28: 1651-1654, 2005. (Pubitemid 41324126)
11. Guo M, Roman RJ, Falck JR, Edwards PA and Scicli AG: Human U251 glioma cell proliferation is suppressed by HET0016 [N-hydroxy-N′-(4-butyl-2- methylphenyl)formamidine], a selective inhibitor of CYP4A. J Pharmacol Exp Ther 315: 526-533, 2005. (Pubitemid 41500716)
12. Guo AM, Sheng J, Scicli GM, Arbab AS, Lehman NL, Edwards PA, Falck JR, Roman RJ and Scicli AG: Expression of CYP4A1 in U251 human glioma cell induces hyperproliferative phenotype in vitro and rapidly growing tumors in vivo. J Pharmacol Exp Ther 327: 10-19, 2008.
13. Alonso-Galicia M, Falck JR, Reddy KM and Roman RJ: 20-HETE agonists and antagonists in the renal circulation. Am J Physiol 277: F790-F796, 1999.
14. Powell PK, Wolf I, Jin R and Lasker JM: Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11. J Pharmacol Exp Ther 285: 1327-1336, 1998. (Pubitemid 28277936)
15. Wang D and Dubois RN: Measurement of eicosanoids in cancer tissues. Methods Enzymol 433: 27-50, 2007.
16. Murray GI: The role of cytochrome P450 in tumour development and progression and its potential in therapy. J Pathol 192: 419-426, 2000.
17. Akbulut T, Regner KR, Roman RJ, Avner ED, Falck JR and Park F: 20-HETE activates the Raf/MEK/ERK pathway in renal epithelial cells through an EGFR-and c-Src-dependent mechanism. Am J Physiol Renal Physiol 297: F662-F670, 2009.